Skip to Main Content

WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on Sunday, and now only Medicare patients will see relief at the pharmacy counter.

Back in November, the party had grand ambitions of capping insulin costs at $35 per month for all patients with insurance. But when they tried to insert the policy into the sweeping climate, tax, and health care package they’re advancing this month, it conflicted with Senate rules. Now, the plan only caps out-of-pocket costs for Medicare patients who use insulin, around a quarter of whom pay more than $35 per month right now.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment